RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 177 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $168,262 | -59.5% | 25,807 | +2.3% | 0.00% | -100.0% |
| Q1 2024 | $415,324 | +46.2% | 25,217 | -2.3% | 0.00% | 0.0% |
| Q4 2023 | $284,135 | +30.9% | 25,807 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $217,037 | -32.6% | 25,807 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $321,875 | -22.5% | 25,627 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $415,324 | +10.2% | 25,217 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $376,742 | -48.0% | 25,217 | -22.2% | 0.00% | -50.0% |
| Q3 2022 | $725,000 | +33.5% | 32,417 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $543,000 | +6.3% | 32,417 | +89.8% | 0.00% | 0.0% |
| Q1 2022 | $511,000 | -2.5% | 17,077 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $524,000 | +15.2% | 17,077 | +18.4% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -12.0% | 14,426 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $517,000 | +53.9% | 14,126 | +45.3% | 0.00% | 0.0% |
| Q1 2021 | $336,000 | +15.9% | 9,720 | +39.5% | 0.00% | 0.0% |
| Q4 2020 | $290,000 | – | 6,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |